Biosteron

DRUG2 trials

Sponsors

Charite Universitaetsmedizin Berlin KöR, The Pharmaceutical Company LEK-AM Sp. Zoo., Przedsiebiorstwo Farmaceutyczne Lek-Am Sp. z o.o.

Conditions

MenopauseTreatment Resistant Depression (TRD)sleep disorders in the postmenopausal period

Phase 3

A randomized, double-blind, placebo-controlled, multicenter study evaluating the effect of a 12-week DHEA combination of 20 mg and 2 mg prolonged-release melatonin on sleep quality and mood in postmenopausal women.

RecruitingCTIS2024-520234-30-00

The Pharmaceutical Company LEK-AM Sp. Zoo., Przedsiebiorstwo Farmaceutyczne Lek-Am Sp. z o.o.Menopause, sleep disorders in the postmenopausal period

Start: 2024-11-30Target: 100Updated: 2025-05-13

Dehydroepiandrosterone (DHEA) as augmentation of standard antidepressants in treatment-resistant depression: a randomized controlled trial (DARE-Trial) - A multicenter, randomized, double-blind, placebo-controlled trial with group sequential design

Not yet recruitingCTIS2024-517963-21-00

Charite Universitaetsmedizin Berlin KöRTreatment Resistant Depression (TRD)

Target: 320Updated: 2025-12-23